CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
narafilcon B +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01444287
NCT01444287N/ACompleted

Daytime Corneal Swelling During Wear of Narafilcon B Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Sep 30, 2011·Updated Jun 19, 2018

In Brief

A clinical study evaluating narafilcon B, Polymacon, and 2 other interventions for Myopia. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The purpose of this research is to measure daytime open-eye response to wearing of narafilcon B lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesAustralia
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 30, 2011
Enrollment StartJan 1, 2010
Primary CompletionFeb 1, 2010
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.8 years ago

Interventions

narafilcon Bdevice

test product

Polymacondevice

marketed product

Lotrafilcon Adevice

marketed product

Spectaclesother

None - subject used own spectacles